|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 501/04 |
| (11) | Number of the document | 3180347 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15832439.2 |
| Date of filing the European patent application | 2015-08-14 | |
| (97) | Date of publication of the European application | 2017-06-21 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/045287 |
| Date | 2015-08-14 |
| (87) | Number | WO 2016/025839 |
| Date | 2016-02-18 |
| (30) | Number | Date | Country code |
| 201462037676 P | 2014-08-15 | US | |
| 201462065993 P | 2014-10-20 | US | |
| 201562111840 P | 2015-02-04 | US |
| (72) |
WALLER, David, US
GAZDA, Gregory, US
MINDEN, Zachary, US
BARTON, Lisa, US
LEIGH, Clifton, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
| (54) | SYNTHESIS OF CEPHALOSPORIN COMPOUNDS |
| SYNTHESIS OF CEPHALOSPORIN COMPOUNDS |